Showing results (251-260 of 318) with videos related to

Sort By:
Pageof 32
BJU International|September 14, 2013
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancerAbdel-Rahmène Azzouzi, Eric Barret, Caroline M Moore, et al.
Magnetic Resonance Imaging|January 4, 2020
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculationsFrancesco Giganti, Martina Pecoraro, Davide Fierro, et al.
BMJ Open|January 30, 2020
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysisJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
BMJ Open|October 5, 2018
Can the completeness of radiological cancer staging reports be improved using proforma reporting? A prospective multicentre non-blinded interventional study across 21 centres in the UKAnisha Patel, Andrea Rockall, Ashley Guthrie, et al.
European Radiology|December 18, 2019
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot studyFrancesco Giganti, Martina Pecoraro, Vasilis Stavrinides, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 7, 2023
Picture Perfect: The Status of Image Quality in Prostate MRIAlexandre Woernle, Cameron Englman, Louise Dickinson, et al.
The British Journal of Radiology|September 21, 2020
Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISEFrancesco Giganti, Vasilis Stavrinides, Armando Stabile, et al.
The Journal of Urology|October 16, 2012
Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancerVeeru Kasivisvanathan, Robert Dufour, Caroline M Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
European Urology|May 4, 2020
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort StudyVasilis Stavrinides, Francesco Giganti, Bruce Trock, et al.
Pageof 32